Given that amplification and/or overexpression of c-Myc is frequently detected in human endometrial cancer and correlates with worse overall prognosis [14], we investigated the inhibitory effects of JQ1 in endometrial cancer both in vitro and in vivo. This evidence concerns the gene MYC and endometrial cancer.